Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPRELSA for Thyroid cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where CAPRELSA was used for Thyroid cancer.

Most Reported Side Effects for CAPRELSA

Side Effect Reports % Deaths Hosp.
Pancreatitis 9 29.0% 0 9
Renal failure 7 22.6% 1 1
Blood creatinine increased 5 16.1% 0 0
Renal failure acute 5 16.1% 0 5

Other Indications for CAPRELSA

Medullary thyroid cancer (14)

Other Drugs Used for Thyroid cancer

LENVATINIB (2,668) CABOZANTINIB S-MALATE (1,615) VANDETANIB (591) DABRAFENIB (583) TRAMETINIB DIMETHYL SULFOXIDE (482) SORAFENIB (399) LEVOTHYROXINE (299) PAZOPANIB (264) PRALSETINIB (199) CABOZANTINIB (125)

Related Pages

CAPRELSA Full Profile All Thyroid cancer Drugs CAPRELSA Demographics CAPRELSA Timeline